首页|血清SCC-Ag、HE4、SMAD4水平与宫颈癌放化疗敏感性的相关性分析

血清SCC-Ag、HE4、SMAD4水平与宫颈癌放化疗敏感性的相关性分析

扫码查看
目的 分析血清鳞状细胞癌相关抗原(SCC-Ag)、人附睾分泌蛋白4(HE4)、SMAD4水平与宫颈癌放化疗敏感性的相关性.方法 选取接受放化疗治疗的宫颈癌患者74例为研究对象,根据放化疗敏感性分为抵抗组和敏感组,分别有48例和26例.检测患者治疗前后血清SCC-Ag、HE4及SMAD4 mRNA水平,分析治疗前血清SCC-Ag、HE4、SMAD4水平与超声参数的相关性.绘制受试者工作特征曲线(ROC)描述治疗前SCC-Ag、HE4及SMAD4 mRNA水平对放化疗敏感性的预测价值.结果 治疗后2组患者血清SCC-Ag、HE4水平较治疗前降低,SMAD4 mRNA水平较治疗前升高(P<0.05);且敏感组患者治疗前、后SCC-Ag、HE4水平均低于抵抗组,SMAD4 mRNA水平均高于抵抗组(P<0.05).治疗前血清 SCC-Ag、HE4 与 Ⅵ 呈正相关(y=0.518、0.544,P<0.05),SMAD4 mRNA 与 Ⅵ 呈负相关(y=-0.581,P<0.05).ROC曲线显示,治疗前SCC-Ag、HE4及SMAD4 mRNA联合对放化疗敏感性的预测价值较高,AUC为0.863(95%CI:0.764~0.962).结论 血清SCC-Ag、HE4及SMAD4 mRNA水平与宫颈癌放化疗敏感性密切相关,且三者联合对放化疗敏感性具有较高的预测价值.
Correlation Between Serum SCC-Ag,HE4,SMAD4 and Chemoradiotherapy Sensitivity of Cervical Cancer
Objective To analyze the correlation between serum squamous cell carcinoma associated antigen(SCC-Ag),human epididymal secretory protein 4(HE4),SMAD4 and radiochemotherapy sensitivity of cervical cancer.Methods A total of 74 patients with cervical cancer underwent radiochemotherapy were enrolled as the research objects.According to radiochemother-apy sensitivity,they were divided into resistance group(48 cases)and sensitivity group(26 cases).The levels of serum SCC-Ag,HE4 and SMAD4 mRNA were detected before and after treatment,relation between levels of serum SCC-Ag,HE4 and SMAD4 and ultrasound parameters were analyzed,and their predictive value for radiochemotherapy sensitivity was evaluated by receiver operat-ing characteristic(ROC)curves.Results After treatment,mRNA levels of serum SCC-Ag and HE4 were decreased,while level of SMAD4 mRNA was increased in both groups(P<0.05).Before and after treatment,levels of SCC-Ag and HE4 in sensitivity group were lower than those in resistance group,while level of SMAD4 mRNA was higher than that in resistance group(P<0.05).Before treatment,levels of serum SCC-Ag and HE4 were positively correlated with Ⅵ(y=0.518,0.544,P<0.05),while SMAD4 mRNA was negatively correlated with it(y=-0.581,P<0.05).ROC curves analysis showed that predictive value of SCC-Ag combined with HE4 and SMAD4 was high for radiochemotherapy sensitivity(AUC=0.863(95%CI:0.764~0.962).Conclusion The levels of serum SCC-Ag,HE4 and SMAD4 mRNA are closely related to radiochemotherapy sensitivity of cervi-cal cancer,and combined detection has higher predictive value for radiochemotherapy sensitivity.

Cervical cancerSquamous cell carcinoma associated antigenHuman epididymal secretory protein 4SMAD4Radiochemotherapy sensitivity

薛慧莹、孟芳、易利霞

展开 >

450000 郑州大学第五附属医院

宫颈癌 鳞状细胞癌相关抗原 人附睾分泌蛋白4 SMAD4 放化疗敏感性

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(5)
  • 17